A Study of YPEG-rhEPO in Patients Suffered From Anemia Due to Chronic Kidney Disease
Clinical trial NCT04885647 · COMPLETED
Trial details
- NCT number
- NCT04885647
- Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-12
- Primary completion
- 2022-01-05
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.